Dr. Ohad Etzion, Chief of Gastrointestinal and Liver Diseases at Soroka ... In 2017, an estimated 10.6 million people globally were affected by decompensated cirrhosis, and the available treatment ...

An AI algorithm built on echocardiogram videos could help opportunistically screen for steatotic liver disease and cirrhosis.

Dr. Ohad Etzion, Chief of Gastrointestinal and Liver ... people globally were affected by decompensated cirrhosis, and the available treatment options remain scarce, especially for patients ...

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

At least 250,000 US hospitalized patients a year require enteral support using an artificial pathway into the gastrointestinal (GI) tract to deliver nutrition or medication. In light of this ...

Madrigal Pharmaceuticals' Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity. See why I have a ...

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...

A new study found that alcohol-related liver and pancreas problems are increasing disproportionately among adolescents and ...